DBTX
Price:
$4.91
Market Cap:
$123.37M
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to address hearing disorders caused by single gene mutations; Gene Therapies for Hair Cell Regeneration designed to replace lost hair cells within the inner ear to address acquired hearing loss and balance disorders; and Otoprotection Therapeutic in clinical development to prevent hearing loss in cancer patients undergoing chemotherapy with cisplatin. T...[Read more]
Industry
Biotechnology
IPO Date
2021-02-12
Stock Exchange
NASDAQ
Ticker
DBTX
According to Decibel Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.93. This represents a change of 57.90% compared to the average of -1.22 of the last 4 quarters.
The mean historical PE Ratio of Decibel Therapeutics, Inc. over the last ten years is -4.13. The current -1.93 PE Ratio has changed 4.58% with respect to the historical average. Over the past ten years (40 quarters), DBTX's PE Ratio was at its highest in in the December 2022 quarter at -0.80. The PE Ratio was at its lowest in in the December 2020 quarter at -8.09.
Average
-4.13
Median
-3.21
Minimum
-11.08
Maximum
-0.81
Discovering the peaks and valleys of Decibel Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 244.62%
Maximum Annual PE Ratio = -0.81
Minimum Annual Increase = -82.39%
Minimum Annual PE Ratio = -11.08
Year | PE Ratio | Change |
---|---|---|
2022 | -0.81 | -58.36% |
2021 | -1.95 | -82.39% |
2020 | -11.08 | 244.62% |
2019 | -3.21 | -11.17% |
The current PE Ratio of Decibel Therapeutics, Inc. (DBTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.61
5-year avg
-4.13
10-year avg
-4.13
Decibel Therapeutics, Inc.’s PE Ratio is less than Werewolf Therapeutics, Inc. (-1.64), greater than Edgewise Therapeutics, Inc. (-14.14), greater than Celcuity Inc. (-7.01), greater than C4 Therapeutics, Inc. (-3.44), less than Aerovate Therapeutics, Inc. (-0.62), greater than Adagene Inc. (-2.86), greater than Acrivon Therapeutics, Inc. Common Stock (-4.23), greater than Rezolute, Inc. (-3.80), less than AN2 Therapeutics, Inc. (-0.47), less than Ikena Oncology, Inc. (-1.22), greater than Eliem Therapeutics, Inc. (-3.49), greater than Anebulo Pharmaceuticals, Inc. (-4.99), less than HCW Biologics Inc. (-0.69), greater than Molecular Partners AG (-2.67),
Company | PE Ratio | Market cap |
---|---|---|
-1.64 | $88.28M | |
-14.14 | $1.64B | |
-7.01 | $557.67M | |
-3.44 | $374.42M | |
-0.62 | $54.85M | |
-2.86 | $115.55M | |
-4.23 | $250.26M | |
-3.80 | $240.80M | |
-0.47 | $30.44M | |
-1.22 | $81.56M | |
-3.49 | $495.57M | |
-4.99 | $46.68M | |
-0.69 | $26.62M | |
-2.67 | $182.90M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Decibel Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Decibel Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Decibel Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Decibel Therapeutics, Inc. (DBTX)?
What is the highest PE Ratio for Decibel Therapeutics, Inc. (DBTX)?
What is the 3-year average PE Ratio for Decibel Therapeutics, Inc. (DBTX)?
What is the 5-year average PE Ratio for Decibel Therapeutics, Inc. (DBTX)?
How does the current PE Ratio for Decibel Therapeutics, Inc. (DBTX) compare to its historical average?